Anti-CEA antibody can also be considered as an alternative for the detection of colon cancer [9,10,11]; however, in contrast to antibodies, aptamers offer the key advantages of greater specificity and affinity binding with target molecules. This evidence concerns the gene CEACAM5 and colonic neoplasm.